Efficacy, Safety, and Impact on the Quality of Life of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis
Guselkumab, a monoclonal antibody that targets the interleukin-23 p19 subunit, has demonstrated considerable efficacy in the management of moderate-to-severe plaque psoriasis and psoriatic arthritis through the inhibition of inflammatory pathways that are central to disease pathology. Series of exte...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Termedia Publishing House
2025-12-01
|
| Saila: | Przegląd Dermatologiczny |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.termedia.pl/Efficacy-Safety-and-Impact-on-the-Quality-of-Life-r-nof-Guselkumab-in-the-Treatment-of-Moderate-to-Severe-Plaque-r-nPsoriasis-and-Psoriatic-Arthritis,56,57431,1,1.html |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|